[The clinical significance of saliva beta(2)-m in patients with head and neck tumors].

The detection of serum beta(2)-microglobulin is presently used as a marker for malignant tumors.The present paper reports that the quantity of beta(2)-microglobulin in the saliva from patients with head and neck tumors was detected by radioimmunity.The results indicates that the amounts of beta(2)-microglobulin in the saliva of patients with benign tumors(1.